- Home
- CMRX vs CRMD Comparison
CMRX vs CRMD Comparison
Compare CMRX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- CRMD
- Stock Information
- Founded
- CMRX 2000
- CRMD 2006
- Country
- CMRX United States
- CRMD United States
- Employees
- CMRX N/A
- CRMD N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CMRX Health Care
- CRMD Health Care
- Exchange
- CMRX Nasdaq
- CRMD Nasdaq
- Market Cap
- CMRX 797.3M
- CRMD 645.0M
- IPO Year
- CMRX 2013
- CRMD 2010
- Fundamental
- Price
- CMRX $8.54
- CRMD $7.67
- Analyst Decision
- CMRX Hold
- CRMD Strong Buy
- Analyst Count
- CMRX 4
- CRMD 6
- Target Price
- CMRX $8.51
- CRMD $14.50
- AVG Volume (30 Days)
- CMRX 2.0M
- CRMD 2.6M
- Earning Date
- CMRX 04-30-2025
- CRMD 05-08-2025
- Dividend Yield
- CMRX N/A
- CRMD N/A
- EPS Growth
- CMRX N/A
- CRMD N/A
- EPS
- CMRX N/A
- CRMD N/A
- Revenue
- CMRX $212,000.00
- CRMD $43,472,170.00
- Revenue This Year
- CMRX $2,416.04
- CRMD $207.65
- Revenue Next Year
- CMRX $923.92
- CRMD $50.13
- P/E Ratio
- CMRX N/A
- CRMD N/A
- Revenue Growth
- CMRX N/A
- CRMD N/A
- 52 Week Low
- CMRX $0.75
- CRMD $3.61
- 52 Week High
- CMRX $8.55
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- CMRX 80.86
- CRMD 47.85
- Support Level
- CMRX $8.50
- CRMD $6.32
- Resistance Level
- CMRX $8.55
- CRMD $7.71
- Average True Range (ATR)
- CMRX 0.02
- CRMD 0.47
- MACD
- CMRX -0.12
- CRMD 0.23
- Stochastic Oscillator
- CMRX 88.89
- CRMD 92.41
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.